Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rabies Post-exposure Prophylaxis”

31 trials

Showing 20 of 31 results

Post-approval studies (Phase 4)Study completedNCT02991872
What this trial is testing

Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT06433440
What this trial is testing

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

Who this might be right for
Rabies
University of Peshawar 100
Large-scale testing (Phase 3)Study completedNCT02545517
What this trial is testing

Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

Who this might be right for
Virus DiseasesRabies
GlaxoSmithKline 459
Testing effectiveness (Phase 2)Study completedNCT03961555
What this trial is testing

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Who this might be right for
Rabies
Synermore Biologics Co., Ltd. 448
Large-scale testing (Phase 3)Study completedNCT01107275
What this trial is testing

Early Rabies Vaccine Immunization in Primary School Children

Who this might be right for
Rabies Prevention
Provincial Public Health Office, Phetchabun 703
Post-approval studies (Phase 4)UnknownNCT01173302
What this trial is testing

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Who this might be right for
Rabies
Peking University People's Hospital 160
Testing effectiveness (Phase 2)Study completedNCT00708084
What this trial is testing

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Who this might be right for
Rabies
Crucell Holland BV 48
Not applicableLooking for participantsNCT07327307
What this trial is testing

Real World Evidence Study of SYN023 in Children Exposed to Rabies

Who this might be right for
Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. 232
Large-scale testing (Phase 3)Study completedNCT04478084
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 403
Large-scale testing (Phase 3)Study completedNCT01622062
What this trial is testing

Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Who this might be right for
Rabies
Sanofi Pasteur, a Sanofi Company 600
Large-scale testing (Phase 3)Study completedNCT02040090
What this trial is testing

Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects

Who this might be right for
Rabies
Kamada, Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT00656097
What this trial is testing

Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Who this might be right for
Rabies
Crucell Holland BV 140
Large-scale testing (Phase 3)Study completedNCT03700242
What this trial is testing

Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year

Who this might be right for
Healthy Volunteers (Rabies Immunization)
Sanofi Pasteur, a Sanofi Company 570
Large-scale testing (Phase 3)Not Yet RecruitingNCT07055893
What this trial is testing

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Who this might be right for
Rabies (Healthy Volunteers)
Sinovac Biotech Co., Ltd 390
Not applicableStudy completedNCT04829630
What this trial is testing

Immunity Persistence After Abridged Intradermal Rabies PEP

Who this might be right for
Rabies
Institut Pasteur 180
Large-scale testing (Phase 3)UnknownNCT05667974
What this trial is testing

Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

Who this might be right for
RabiesPrevention
Yisheng Biopharma (Singapore) Pte. Ltd. 4,500
Post-approval studies (Phase 4)Study completedNCT01365494
What this trial is testing

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Who this might be right for
Rabies
Novartis Vaccines 250
Not applicableStudy completedNCT05684185
What this trial is testing

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Who this might be right for
Rabies Post-exposure Prophylaxis
Institut Pasteur du Cambodge 215
Post-approval studies (Phase 4)Study completedNCT02564471
What this trial is testing

Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.

Who this might be right for
Rabies
State University of New York - Upstate Medical University 103
Not applicableActive Not RecruitingNCT07624461
What this trial is testing

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

Who this might be right for
Rabies Post-exposure ProphylaxisRabies
Synermore Biologics (Suzhou) Co., Ltd. 80
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation